Company news: CSL Behring and McGraw-Hill

Share this article:
CSL Behring awarded advocacy grants worth around $100,000 to six patient groups through its Local Empowerment for Advocacy Development program, which supports groups helping patients using plasma-derived or recombinant therapies for rare and serious diseases, including bleeding disorders, immune deficiencies and hereditary angioedema.

McGraw-Hill launched mobile versions of its AccessMedicine and AccessPharmacy sites for healthcare professionals. The publisher currently supports iPhone and iPhone 3G, Android and BlackBerry Bold.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.